Divis' Laboratories Share Price
(DIVISLAB)
Check the latest share price of Divis' Laboratories, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
₹6108
▲1.35%
as on 04:01PM, 29 Apr 2025
NSE
Divis' Laboratories Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹5,916Day's Price Range₹6,13052 Week's Low
52 Week's High
₹3,72452-Week Price Range₹6,308.5
| Returns % | |
| 1 Month Return | -1.44 % |
| 3 Month Return | -4.89 % |
| 1 Year Return | + 50.39 % |
| Market Stats | |
| Previous Close | ₹6,026.50 |
| Open | ₹6,055.00 |
| Volume | 6.40L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,48,378.35Cr |
Divis' Laboratories Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹1,48,378.35 Cr
Return on Equity (ROE)
28.13
Return on capital employed (ROCE)
35.01
P/B Ratio
10
Dividend Yield
0.68
EPS (TTM)
111.53
Sector
Pharmaceuticals
How to invest in Divis' Laboratories
Investing in Divis' Laboratories is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Divis' Laboratories or DIVISLAB on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Divis' Laboratories or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Divis' Laboratories with just a few clicks!
Divis' Laboratories Valuation
Track how the P/E of Divis' Laboratories has moved over time to understand valuation trends.
Divis' Laboratories in the last 5 years
Lowest (28.97x)
November 21, 2022
Industry (58.33x)
December 15, 2023
Today (73.69x)
December 15, 2023
Highest (75.70x)
December 4, 2023
Today’s Price to Earnings Ratio: 73.69x
Analysts Recommendation on Divis' Laboratories
Get updated buy, sell, and hold recommendations by analysts on Divis' Laboratories.
based on 25 analysts
32.00%
Buy
24.00%
Hold
44.00%
Sell
44% of analysts recommend a 'HOLD' rating for Divis' Laboratories. Average target of ₹3346.96
Source: S&P Global Market Intelligence
Analysts Forecast on Divis' Laboratories
Get share price movements and forecasts by analysts on Divis' Laboratories.
Divis' Laboratories price forecast by 25 analysts
Downside of
High
₹4300
Target
₹3346.96
Low
₹2615
Divis' Laboratories target price ₹3346.96, a slight downside of -40.12% compared to current price of ₹6108. According to 25 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Divis' Laboratories revenue growth forecast
Expected growth rate Q1, FY2025:22.56%
Forecast
Actual
Including amortisation and stock based compensations
Divis' Laboratories EPS growth forecast
EPS estimate Q1, FY2025:31.69%
Forecast
Actual
Source: S&P Global Market Intelligence
Divis' Laboratories Financials
Get the annual and quarterly financial summary of Divis' Laboratories, including revenue, profit, loss and more.
Divis' Laboratories Index Inclusions
Divis' Laboratories Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Divis' Laboratories.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 51.94% | 0.00 | |
| Foreign Institutions | 14.68% | 0.00 | |
| Mutual Funds | 13.15% | 0.00 | |
| Retail Investors | 12.31% | 0.00 | |
| Others | 7.92% | 0.00 |
Divis' Laboratories vs Peers
Compare market cap, revenue, PE, and other key metrics of Divis' Laboratories with its industry peers.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹1,48,378.35 Cr | 26.67% | 0.50 | NA | NA | |
| BUY | ₹1,05,894.82 Cr | 34.5% | 0.68 | NA | NA | |
| BUY | ₹38,004.99 Cr | -1.21% | 0.51 | NA | NA | |
| HOLD | ₹22,962.93 Cr | -4.68% | 0.50 | NA | NA | |
| BUY | ₹1,18,158.42 Cr | 29.4% | 0.50 | NA | NA |
Divis' Laboratories News & Key Events
Latest news and events at one place to help you take investing decisions in Divis' Laboratories.
Citigroup Initiates Buy Rating on Divis Laboratories - 25 Apr, 2025
Citigroup has assigned a buy rating to Divis Laboratories with a target price of Rs 7,050. Analysts highlight the company's potential as a primary supplier due to capacity expansion and the upcoming addition of Orforglipron in its pipeline. The stock is considered a top pick in the pharma sector.Divis Laboratories Gains on Positive Brokerage Ratings - 24 Apr, 2025
Divis Laboratories saw significant stock gains after Citi raised its price target to ₹7,050, highlighting strong growth potential in GLP-1 products. Despite some caution from analysts, the overall sentiment remains positive as the company expands its capacity and product pipeline.Divis Labs Secures Long-Term Pharma Supply Agreement - 18 Apr, 2025
Divis Laboratories has entered a long-term manufacturing and supply agreement with a global pharmaceutical company, focusing on advanced intermediates. The company plans to invest ₹650-700 crore for capacity expansion, expecting significant revenue contributions from this partnership.Divis Laboratories Shares Drop Amid Tariff Concerns - 04 Apr, 2025
Divis Laboratories shares fell over 6% to ₹5,410.60 following U.S. President Trump's comments on potential tariffs on pharmaceutical imports, raising investor concerns. The stock's decline reflects fears of increased manufacturing costs and policy risks for companies exporting to the U.S.Divis Laboratories Shares Rise on Positive Recommendations - 03 Apr, 2025
Divis Laboratories shares saw a 1.90% increase following tariff exemptions for pharmaceuticals. SBI Securities recommends buying with targets of Rs 5,830 and Rs 5,900.Divis Labs Positioned for Growth Amid Industry Challenges - 01 Apr, 2025
Divis Laboratories is poised for continued success with a strong growth trajectory, debt-free balance sheet, and strategic expansions. The ramp-up of its Kakinada facility is expected to enhance margins, with a price target of Rs 7,008 anticipated in 8 to 10 months.Concerns Over Tariffs Impacting Pharma Sector - 30 Mar, 2025
India's 10% tariff on US pharma imports raises concerns among industry groups, highlighting potential cost burdens for distributors and generic manufacturers amid minimal US duties.Divis Laboratories Excluded from Index, Faces Volatility - 28 Mar, 2025
Divis Laboratories has faced a volatile market since its exclusion from the index in September 2024, as noted in recent reports.
Insights on Divis Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, DIVISLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 11.89% to 12.83% in Mar 2025 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 17.99% to 18.01% in Mar 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 430.0 Cr → 589.0 Cr (in ₹), with an average increase of 14.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, DIVISLAB stock has moved up by 2.0%
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 51.89% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 103.2%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 9.59% to 9.39% in Mar 2025 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 2.44K Cr → 2.40K Cr (in ₹), with an average decrease of 1.8% per quarter
About Divis' Laboratories
Divis Laboratories Ltd's top products include APIs and intermediates for anti-infectives, cardiovascular, central nervous system, anti-diabetics, gastro-intestinal and anti-inflammatory treatments. The company is also a leader in the manufacture of custom synthesis and process development services for the global pharmaceutical industry.
Divis Laboratories Ltd is the proud owner of several popular brands, including Divis Life, Divis Pharma and Divis Health. Divis Life offers a range of health and wellness products, while Divis Pharma provides a wide range of APIs, intermediates and custom synthesis services.
Revenue: ₹2,118.00Cr as on June 2024 (Q2 24)
Net Profit: ₹430.00Cr as on June 2024 (Q2 24)
Listing date: 12 Mar, 2003
Chairperson Name: Ramesh B V Nimmagadda
| Organisation | Divis' Laboratories |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Divis' Laboratories
Check out the Mutual Funds with significant holdings in Divis' Laboratories.
Futures and Options
View the latest movement in Divis' Laboratories Futures & Options, including strike prices, expiry dates, and percentage changes.
FAQs
What is Divis Laboratories Ltd price today?
Divis Laboratories Ltd share price today stands at ₹6108, Open: ₹6055, Previous Close: ₹6026.5, High: ₹6130, Low: ₹5916, 52 Week High: ₹6308.5, 52 Week Low: ₹3724.
How to Buy Divis Laboratories Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Divis Laboratories Ltd shares
What are today's traded volumes of Divis Laboratories Ltd?
Today's traded volume of Divis Laboratories Ltd(DIVISLAB) is 6.40L.
What is today's market capitalisation of Divis Laboratories Ltd?
Today's market capitalisation of Divis Laboratories Ltd(DIVISLAB) is ₹1,48,378.35 Cr.
What is the 52 Week High and Low Range of Divis Laboratories Ltd?
How much percentage Divis Laboratories Ltd is down from its 52 Week High?
Divis Laboratories Ltd (DIVISLAB) share price is ₹6108. It is down -3.18% from its 52 Week High price of ₹6308.5
How much percentage Divis Laboratories Ltd is up from its 52 Week low?
Divis Laboratories Ltd (DIVISLAB) share price is ₹6108. It is up 64.02% from its 52 Week Low price of ₹3724